Armistice Capital »

Avnet shares owned by Armistice Capital

Quarter-by-quarter ownership of Avnet (AVT) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Avnet

Tip: Access up to 7 years of quarterly data

All positions including Avnet held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avnet by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $522k 5.9k 88.82

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Avnet

BlackRock
Dimensional Fund Advisors
Vanguard Portfolio Management
AQR Capital Management
Greenhaven Associates
Vanguard Capital Management
LSV Asset Management
Pzena Investment Management
American Century Companies
State Street Corporation
FMR
Geode Capital Management
Morgan Stanley
Hotchkis and Wiley Capital Management
Earnest Partners

View all funds holding Avnet